AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21200338 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute resistance exercise protocol (six sets of five-repetition maximum heavy squats)
Number of subjects: 15
Study 21200338 — intervention group
Group type: COMPARATOR
Intervention: Control test (identical conditions with no exercise)
Number of subjects: 15
Study 19491420 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg for 8 weeks
Number of subjects: 52
Study 19491420 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 subjects without UA)
Number of subjects: 52
Study 17206696 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus johnsonii, LA1 (1010 CFU daily for 12 weeks)
Number of subjects: 70
Study 17206696 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus johnsonii, LA1
Number of subjects: 70
Study 15285603 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal logical reasoning
Number of subjects: 0
Study 11584187 — intervention group
Group type: EXPERIMENTAL
Intervention: SNAC heparin (two different doses)
Number of subjects: 0
Study 11584187 — intervention group
Group type: COMPARATOR
Intervention: LMWH (subcutaneous injection)
Number of subjects: 0
Study 9425671 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally cued selection
Number of subjects: 0
Study 9425671 — intervention group
Group type: EXPERIMENTAL
Intervention: Internally generated selection
Number of subjects: 0
Study 8310560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined radiation, drug and estrogen treatments (II)
Number of subjects: 111
Study 8310560 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined estrogens and radiation (IV)
Number of subjects: 111
Study 8310560 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation treatment alone (I)
Number of subjects: 111
Study 8310560 — intervention group
Group type: COMPARATOR
Intervention: Estrogen therapy alone (III)
Number of subjects: 111
Study 2426899 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 0.030 mg ethinylestradiol (EE) plus 0.150 mg levonorgestrel
Number of subjects: 48
Study 2426899 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive containing 0.150 mg levonorgestrel
Number of subjects: 48
Study 31495419 — intervention group
Group type: EXPERIMENTAL
Intervention: Equine-assisted therapy
Number of subjects: 20
Study 28939330 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity programme in the aquatic environment (6 weeks)
Number of subjects: 46
Study 28939330 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 46
Study 27225520 — intervention group
Group type: EXPERIMENTAL
Intervention: Early-term isolated oligohydramnios
Number of subjects: 1213
Study 27225520 — intervention group
Group type: COMPARATOR
Intervention: Full-term isolated oligohydramnios
Number of subjects: 1213
Study 27225520 — intervention group
Group type: EXPERIMENTAL
Intervention: Late-term isolated oligohydramnios
Number of subjects: 1213
Study 27225520 — intervention group
Group type: EXPERIMENTAL
Intervention: Timing of delivery (early-term, full-term, late-term)
Number of subjects: 1213
Study 27225520 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated oligohydramnios cases
Number of subjects: 1213
Study 25074507 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 7141
Study 25074507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7141
Study 25074507 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide and Placebo
Number of subjects: 7141
Study 22607726 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-managed telephone support line and colorectal cancer screening website
Number of subjects: 2280
Study 22607726 — intervention group
Group type: COMPARATOR
Intervention: Standard clinical practice (control)
Number of subjects: 2280
Study 19764907 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Intubation Unit (VIU)
Number of subjects: 40
Study 19764907 — intervention group
Group type: COMPARATOR
Intervention: Conventional laryngoscopy (Control)
Number of subjects: 40
Study 19764907 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 17912998 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultreo ultrasound power toothbrush (ULT)
Number of subjects: 53
Study 17912998 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B 35-MTB)
Number of subjects: 53
Study 15629217 — intervention group
Group type: EXPERIMENTAL
Intervention: Central gaze cues
Number of subjects: 0
Study 15629217 — intervention group
Group type: COMPARATOR
Intervention: Peripheral onset target with an equivalent distractor at the mirror opposite location
Number of subjects: 0
Study 12001058 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 50 mg
Number of subjects: 36
Study 12001058 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg
Number of subjects: 36
Study 12001058 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide 150 mg
Number of subjects: 36
Study 12001058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 12001058 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (all doses)
Number of subjects: 36
Study 10469288 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (estrogen alone or with progestins)
Number of subjects: 293
Study 10469288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study 8652952 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (Desmospray) 40 micrograms for up to 6 weeks
Number of subjects: 71
Study 8652952 — intervention group
Group type: COMPARATOR
Intervention: Enuresis alarm
Number of subjects: 71
Study 8652952 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (enuresis alarm + desmopressin)
Number of subjects: 71
Study 2213631 — intervention group
Group type: EXPERIMENTAL
Intervention: Bair Hugger Warming System
Number of subjects: 91
Study 2213631 — intervention group
Group type: COMPARATOR
Intervention: Warmed bath blankets
Number of subjects: 91
Study 386390 — intervention group
Group type: EXPERIMENTAL
Intervention: Viloxazine (300 mg/d)
Number of subjects: 41
Study 386390 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline (150 mg/d)
Number of subjects: 41
Study 31923017 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL of 2% lidocaine with 1:100,000 adrenaline
Number of subjects: 40
Study 31923017 — intervention group
Group type: COMPARATOR
Intervention: 5 mL of saline solution (control group)
Number of subjects: 40
Study 31437010 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose D. farinae Drops
Number of subjects: 239
Study 31437010 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose D. farinae Drops
Number of subjects: 239
Study 31437010 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 239
Study 28891253 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin plus Suoquan
Number of subjects: 369
Study 28891253 — intervention group
Group type: COMPARATOR
Intervention: Behavioral intervention
Number of subjects: 369
Study 28891253 — intervention group
Group type: COMPARATOR
Intervention: Desmopressin
Number of subjects: 369
Study 25482023 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) at doses of 30 Gy/15 or 25 Gy/10
Number of subjects: 155
Study 25482023 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 155
Study 25482023 — intervention group
Group type: COMPARATOR
Intervention: Not receiving PCI (Control)
Number of subjects: 155
Study 23649684 — intervention group
Group type: EXPERIMENTAL
Intervention: UPPP
Number of subjects: 47
Study 23649684 — intervention group
Group type: EXPERIMENTAL
Intervention: UPPP with RTBR
Number of subjects: 47
Study 21851594 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial and error technique
Number of subjects: 175
Study 21851594 — intervention group
Group type: COMPARATOR
Intervention: Errorless learning method
Number of subjects: 175
Study 19197266 — intervention group
Group type: EXPERIMENTAL
Intervention: sibutramine plus lifestyle modification (combined therapy)
Number of subjects: 194
Study 19197266 — intervention group
Group type: EXPERIMENTAL
Intervention: sibutramine alone
Number of subjects: 194
Study 19197266 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 194
Study 19197266 — intervention group
Group type: COMPARATOR
Intervention: lifestyle modification alone
Number of subjects: 194
Study 16889120 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple pectin-chamomile extract (Diarrhoesan)
Number of subjects: 255
Study 16889120 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 15599313 — intervention group
Group type: EXPERIMENTAL
Intervention: basiliximab + steroids
Number of subjects: 140
Study 15599313 — intervention group
Group type: COMPARATOR
Intervention: basiliximab + placebo
Number of subjects: 140
Study 11412828 — intervention group
Group type: EXPERIMENTAL
Intervention: APSGN children
Number of subjects: 0
Study 9154284 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% isopropyl unoprostone
Number of subjects: 0
Study 9154284 — intervention group
Group type: COMPARATOR
Intervention: 0.5% timolol
Number of subjects: 0
Study 9154284 — intervention group
Group type: EXPERIMENTAL
Intervention: isopropyl unoprostone
Number of subjects: 0
Study 9115686 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride dentifrice (KCl)
Number of subjects: 62
Study 9115686 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride and sodium monofluorphosphate dentifrice (KCl + MFP)
Number of subjects: 62
Study 9115686 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 62
Study 2954458 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-needle vaccination
Number of subjects: 423
Study 2954458 — intervention group
Group type: COMPARATOR
Intervention: One-needle vaccination
Number of subjects: 423
Study 31659214 — intervention group
Group type: EXPERIMENTAL
Intervention: Blurred vision under no-pressure condition
Number of subjects: 0
Study 31659214 — intervention group
Group type: EXPERIMENTAL
Intervention: Blurred vision under tonal-pressure condition
Number of subjects: 0
Study 31659214 — intervention group
Group type: EXPERIMENTAL
Intervention: Blurred vision under tonal + time pressure condition
Number of subjects: 0
Study 31659214 — intervention group
Group type: COMPARATOR
Intervention: Normal vision under no-pressure condition
Number of subjects: 0
Study 31659214 — intervention group
Group type: COMPARATOR
Intervention: Normal vision under tonal-pressure condition
Number of subjects: 0
Study 31659214 — intervention group
Group type: COMPARATOR
Intervention: Normal vision under tonal + time pressure condition
Number of subjects: 0
Study 29609899 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Multimedia Intervention (technology + tailored counseling)
Number of subjects: 160
Study 27842543 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated care centers providing core HIV services (HIV counseling and testing, education, condom distribution, needle exchange, opioid therapy, STI management, TB screening, ART)
Number of subjects: 0
Study 27842543 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no integrated care centers)
Number of subjects: 0
Study 24114397 — intervention group
Group type: EXPERIMENTAL
Intervention: Genistein 54 mg daily
Number of subjects: 262
Study 24114397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 262
Study 22905105 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG treatment
Number of subjects: 6
Study 22905105 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 6
Study 22905105 — intervention group
Group type: EXPERIMENTAL
Intervention: EBV infection
Number of subjects: 6
Study 20618313 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium Administration Rank (MAR)
Number of subjects: 114
Study 18999169 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated, unsupervised, iterative pattern learning approach for constructing a medical dictionary of disease terms.
Number of subjects: 100
Study 14977310 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium hypochloride (NaOCI)
Number of subjects: 14
Study 14977310 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide (H2O2)
Number of subjects: 14
Study 14977310 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of H2O2 and NaOCl
Number of subjects: 14
Study 14977310 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate
Number of subjects: 14
Study 14977310 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide
Number of subjects: 14
Study 14977310 — intervention group
Group type: EXPERIMENTAL
Intervention: Formocresol
Number of subjects: 14
Study 14977310 — intervention group
Group type: COMPARATOR
Intervention: Control group (irrigated with water)
Number of subjects: 14
Study 11697572 — intervention group
Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 39
Study 11697572 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 39
Study 11697572 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 39
Study 11697572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 9250111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake of 1200 mg Ca/d
Number of subjects: 35
Study 9250111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake of 1300 mg Ca/d
Number of subjects: 35
Study 9250111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake > 2 g/d
Number of subjects: 35
Study 9250111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium intake (general)
Number of subjects: 35
Study 9250111 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium retention modeling
Number of subjects: 35
Study 8176052 — intervention group
Group type: EXPERIMENTAL
Intervention: Equal-variance condition
Number of subjects: 6
Study 8176052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-channel covariance condition
Number of subjects: 6
Study 8176052 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-parameter covariance condition
Number of subjects: 6
Study 3234410 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (100 mg bolus followed by 2 mg min‐1 infusion)
Number of subjects: 89
Study 3234410 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone (105 mg bolus followed by 300 mg orally every 8 h)
Number of subjects: 89
Study 3234410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 29947648 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 17
Study 29947648 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 17
Study 27026482 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin (one dose)
Number of subjects: 829
Study 25171035 — intervention group
Group type: EXPERIMENTAL
Intervention: Subepithelial connective tissue graft (CTG)
Number of subjects: 26
Study 25171035 — intervention group
Group type: COMPARATOR
Intervention: Class V composite resin restoration (CRR)
Number of subjects: 26
Study 23160309 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-step test (SST)
Number of subjects: 0
Study 20064881 — intervention group
Group type: EXPERIMENTAL
Intervention: GTH treatment effects
Number of subjects: 661
Study 20064881 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐regulation
Number of subjects: 661
Study 20064881 — intervention group
Group type: EXPERIMENTAL
Intervention: Social‐cognitive variables
Number of subjects: 661
Study 18534485 — intervention group
Group type: EXPERIMENTAL
Intervention: Metal-on-metal hip resurfacing devices
Number of subjects: 337
Study 17038453 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline 100 mg twice daily for 10 days followed by placebo (placebo group)
Number of subjects: 37
Study 17038453 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg twice daily for 10 days followed by continued doxycycline 100 mg twice daily over 4 months (doxycycline group)
Number of subjects: 37
Study 12529867 — intervention group
Group type: EXPERIMENTAL
Intervention: Parametric gamma frailty model applied to long-term follow-up survival data
Number of subjects: 0
Study 12529867 — intervention group
Group type: EXPERIMENTAL
Intervention: Parametric test statistic for testing proportional odds assumption
Number of subjects: 0
Study 11071595 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-enriched formula (1.5 kcal/mL)
Number of subjects: 27
Study 11071595 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (1 kcal/mL)
Number of subjects: 27
Study 11071595 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulas
Number of subjects: 27
Study 8923869 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 200‐mg testosterone pellets (400 mg, 3 mg/day)
Number of subjects: 30
Study 8923869 — intervention group
Group type: EXPERIMENTAL
Intervention: Four 200‐mg testosterone pellets (800 mg, 6 mg/day)
Number of subjects: 30
Study 8923869 — intervention group
Group type: EXPERIMENTAL
Intervention: Four 200‐mg testosterone pellets (800 mg, 6 mg/day) plus a single im injection of 300 mg depot medroxyprogesterone acetate (DMPA)
Number of subjects: 30
Study 8923869 — intervention group
Group type: EXPERIMENTAL
Intervention: All three regimens (two T pellets, four T pellets, and four T pellets plus DMPA)
Number of subjects: 30
Study 8923869 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA
Number of subjects: 30
Study 1526045 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser cautery
Number of subjects: 29
Study 1526045 — intervention group
Group type: COMPARATOR
Intervention: Sub-mucosal diathermy (SMD)
Number of subjects: 29
Study 1526045 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 29
Study 4018502 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (100 micrograms/kg body wt as a bolus intravenously)
Number of subjects: 16
Study 4018502 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (7 micrograms/kg body wt as a bolus)
Number of subjects: 16
Study 4018502 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (40 micrograms/kg body wt as a bolus, followed by 10 micrograms/kg body wt X h)
Number of subjects: 16
Study 4018502 — intervention group
Group type: COMPARATOR
Intervention: Control (no drug)
Number of subjects: 16
Study 31477047 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oxytocin infusion
Number of subjects: 1200
Study 31477047 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion (discontinued oxytocin)
Number of subjects: 1200
Study 29590534 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HIEX)
Number of subjects: 15
Study 29590534 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (IBU) 300 mg
Number of subjects: 15
Study 29590534 — intervention group
Group type: EXPERIMENTAL
Intervention: Water and HIEX
Number of subjects: 15
Study 29590534 — intervention group
Group type: COMPARATOR
Intervention: Water and rest
Number of subjects: 15
Study 29590534 — intervention group
Group type: COMPARATOR
Intervention: IBU and rest
Number of subjects: 15
Study 29590534 — intervention group
Group type: EXPERIMENTAL
Intervention: IBU and HIEX
Number of subjects: 15
Study 27237200 — intervention group
Group type: COMPARATOR
Intervention: SRP only
Number of subjects: 24
Study 27237200 — intervention group
Group type: COMPARATOR
Intervention: SRP and PDT (1% methylene blue solution)
Number of subjects: 24
Study 27237200 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP, PDT, and LLLT
Number of subjects: 24
Study 25121804 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen ER 1300 mg three times daily
Number of subjects: 542
Study 25121804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 542
Study 22382344 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab and golimumab (anti-TNF treatment)
Number of subjects: 2710
Study 22382344 — intervention group
Group type: COMPARATOR
Intervention: DMARD (nonbiological disease-modifying antirheumatic drug)
Number of subjects: 2710
Study 20137821 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine (4 microg/kg/min)
Number of subjects: 30
Study 20137821 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (4 microg/kg/min)
Number of subjects: 30
Study 20137821 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control Group)
Number of subjects: 30
Study 17698968 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 60
Study 17698968 — intervention group
Group type: COMPARATOR
Intervention: Pentobarbital/midazolam/fentanyl regimen
Number of subjects: 60
Study 12890127 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 50 mg plus metoclopramide 10 mg
Number of subjects: 16
Study 12890127 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan 50 mg plus placebo
Number of subjects: 16
Study 10716471 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate renal insufficiency in the SOLVD Prevention Trial
Number of subjects: 0
Study 10716471 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate renal insufficiency in the SOLVD Treatment Trial
Number of subjects: 0
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiogram (ECG) abnormalities in patients with systemic sclerosis
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Conduction disturbances
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarction pattern
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-specific ST-T wave changes
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Right ventricular hypertrophy
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: QTc interval
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Long QTc interval
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-specific ST-T wave abnormalities
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocardiographic signs of right ventricular hypertrophy
Number of subjects: 72
Study 9013267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of right ventricular hypertrophy, right atrial enlargement and right bundle branch block
Number of subjects: 72